Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 494 of 641 · 7,691 filings

  • Somnigroup International (SGI) FY2024 10-K risk factors
    19 risks

    The risk section is dominated by integration challenges from the Mattress Firm acquisition, raw material cost volatility, and leverage.

    Filed Feb 28, 2025
  • abrdn Gold ETF Trust (SGOL) FY2024 10-K risk factors
    29 risks

    The Trust's risks are dominated by gold price volatility, physical custody vulnerabilities, and operational dependencies on Authorized Participants and the Custodian. Shareholders face lack of regulatory protections under the Investment Company Act of 1940 and absence of gold insurance.

    Filed Feb 28, 2025
  • abrdn Silver ETF Trust (SIVR) FY2024 10-K risk factors
    26 risks

    The risk factors are dominated by silver price volatility, physical custody risks, lack of regulatory protections, and reliance on third-party service providers like the Custodian.

    Filed Feb 28, 2025
  • Solid Power (SLDPW) FY2024 10-K risk factors
    65 risks

    Solid Power faces heavy risks in scaling sulfide-based solid electrolyte production and securing commercial partner agreements. The company remains in a pre-revenue R&D stage with persistent operating losses. Future success depends entirely on EV market adoption and protecting proprietary solid-state battery intellectual property.

    Filed Feb 28, 2025
  • Standard Motor Products (SMP) FY2024 10-K risk factors
    24 risks

    Customer concentration is high, with O’Reilly Auto Parts, AutoZone, and NAPA generating 60.7% of 2024 net sales.

    Filed Feb 28, 2025
  • Solventum (SOLV) FY2024 10-K risk factors
    37 risks

    Solventum Corporation faces significant risks following its spin-off from 3M, including $8.0 billion in debt obligations. The company is heavily reliant on 3M as the sole source of supply for raw materials representing $3 billion in revenue. Solventum lacks access to 3M's research and development resources and faces strict regulatory compliance and potential PFAS liabilities.

    Filed Feb 28, 2025
  • Sarepta Therapeutics (SRPT) FY2024 10-K risk factors
    70 risks

    Sarepta faces heavy risks around commercial adoption, regulatory approval conditions, and third-party manufacturing dependencies for its rare disease therapies. The company relies heavily on maintaining reimbursement coverage and navigating strict post-approval requirements for products like Elevidys and its PMO portfolio.

    Filed Feb 28, 2025
  • Sensata Technologies Holding (ST) FY2024 10-K risk factors
    29 risks

    Sensata Technologies faces significant risks from cyclical automotive and transportation demand, component cost inflation, and material weaknesses in internal financial controls.

    Filed Feb 28, 2025
  • Stewart Information Services (STC) FY2024 10-K risk factors
    23 risks

    Stewart Information Services faces severe vulnerability to housing market cycles, mortgage interest rates, and real estate activity levels. Disruptive industry innovations, title waivers, and independent agent dependencies threaten core title insurance revenues. Strict regulatory oversight, cyber threats, and potential reserve inadequacies for title losses pose additional material risks.

    Filed Feb 28, 2025
  • Steel Dynamics (STLD) FY2024 10-K risk factors
    20 risks

    Steel Dynamics faces significant exposure to global steel overcapacity, raw material price volatility, and cyclical demand in construction and manufacturing. Execution risks surround major capital projects like the Sinton Flat Roll Division and recycled aluminum mill expansions. Environmental regulations, GHG emission reduction targets, and energy cost volatility pose ongoing operational hurdles.

    Filed Feb 28, 2025
  • Sun Communities (SUI) FY2024 10-K risk factors
    51 risks

    Safe Harbor sale creates $5.65 billion pending transaction with broad deployment discretion and integration risks. CEO Gary Shiffman announced his upcoming retirement by the end of 2025. A material weakness in internal controls over financial reporting was identified.

    Filed Feb 28, 2025
  • Teleflex (TFX) FY2024 10-K risk factors
    33 risks

    Teleflex faces significant strategic execution risks regarding the proposed separation of its Urology, Acute Care, and OEM businesses. The company carries $1.7 billion in total consolidated indebtedness with restrictive debt covenants. Operations rely heavily on single manufacturing locations, key distributor channels, and ethylene oxide sterilization.

    Filed Feb 28, 2025

Companies covered

4,011 companies

371 more under A